{"cluster": 26, "subcluster": 3, "abstract_summ": "As hospitals cope with the influx of COVID-19 patients, new challenges have arisen as healthcare systems care for COVID-19 patients while still providing essential emergency care for patients with acute strokes and acute myocardial infarction.We describe four COVID-19 patients treated with intravenous thrombolysis for acute ischaemic stroke.In this paper, we detail our experience caring for acute stroke patients, and provide some insight into neurointerventional workflow modifications that have helped us adapt to the COVID-19 era.Understanding the natural history and appropriate management of COVID-19 patients presenting with ST elevation is essential to inform patient management decisions and protect healthcare workers.This registry will enroll confirmed COVID-19 patients and persons under investigation (PUI) with new ST-segment elevation or new onset left bundle branch block (LBBB) on the ECG with clinical suspicion of myocardial ischemia.", "title_summ": "Insights from a British cardiac centerConsiderations for Management of Acute Coronary Syndromes During the SARS-CoV-2 (COVID-19) PandemicThe experience of treating patients with acute myocardial infarction under the COVID\u201019 epidemicTriage of Acute Ischemic Stroke in Confirmed COVID-19: Large Vessel Occlusion Associated With Coronavirus InfectionNeuroendovascular Treatment of Acute Stroke during Covid-19: A Guide from the FrontlinesA single-centre experience of intravenous thrombolysis for stroke in COVID-19 patientsCollateral Damage: Medical Care Avoidance Behavior Among Patients With Myocardial Infarction During the COVID-19 PandemicManagement of ST\u2010segment\u2010elevation myocardial infarction during the coronavirus disease 2019 (COVID\u201019) outbreak: Iranian\u201c247\u201d National Committee's position paper on primary percutaneous coronary interventionManagement and Outcomes of ST-segment Elevation Myocardial Infarction During Coronavirus 2019 Pandemic in a Center with 24/7 Primary Angioplasty Capability: Should We Change Our Practice During Outbreak?North American COVID-19 ST-segment elevation myocardial infarction (NACMI) registry: Rationale, design, and implications()Treatment of ST-segment elevation myocardial infarction during COVID-19 pandemicImpact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction:Impact of COVID-19 Pandemic on Critical Care Transfers for ST-Elevation Myocardial Infarction, Stroke, and Aortic Emergencies.Clinical Pathway for Management of Suspected or Positive Novel Coronavirus-19 Patients With ST-Segment Elevation Myocardial Infarction.", "title_abstract_phrases": "As hospitals cope with the influx of COVID-19 patients, new challenges have arisen as healthcare systems care for COVID-19 patients while still providing essential emergency care for patients with acute strokes and acute myocardial infarction.However, further studies are needed to determine a standard protocol for emergency managementNorth American COVID-19 ST-segment elevation myocardial infarction (NACMI) registry: Rationale, design, and implications()BACKGROUND: The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that causes coronavirus disease 2019 (COVID-19), has resulted in a global pandemic.We describe four COVID-19 patients treated with intravenous thrombolysis for acute ischaemic stroke.A single-centre experience of intravenous thrombolysis for stroke in COVID-19 patientsThe sudden worldwide outbreak of Coronavirus Disease 2019 (COVID-19) has certainly provided new challenges in the management of acute ischaemic stroke, and the risk-benefit ratio of intravenous thrombolysis in COVID-19 positive patients is not well known.In this paper, we detail our experience caring for acute stroke patients, and provide some insight into neurointerventional workflow modifications that have helped us adapt to the COVID-19 era."}